Bellatora Inc. (ECGR)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bellatora Inc. (ECGR) trades at $0.80 with AI Score 49/100 (Grade C). Bellatora Inc. operates in the electronic vaporizer and eLiquid market, catering to tobacco and medicinal cannabis users. Market cap: $13.39M, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for ECGR: ECGR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ECGR against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ECGR: the 1 perspectives are evenly split.
How is this calculated? →Bellatora Inc. (ECGR) Financial Services Profile
Bellatora Inc., formerly Oncology Med, manufactures and distributes electronic vaporizers, eLiquids, and ecigars. Operating in the competitive and evolving vaping market, the company targets tobacco and medicinal cannabis users. Its financial performance reflects the challenges of a small-cap OTC-listed entity in the financial services sector.
What Is the Investment Thesis for ECGR?
Investing in Bellatora Inc. (ECGR) requires careful consideration of its financial standing and market position. With a market capitalization of $13.39M and a negative P/E ratio of -0.68, the company's profitability is a concern. The negative profit margin of -1562.3% indicates significant losses. The gross margin of 47.9% suggests potential in product pricing, but operational inefficiencies weigh heavily. Growth catalysts depend on successful product innovation and market penetration in the competitive vaping sector. The high beta of 2.76 indicates high volatility, making it a speculative investment. Investors should closely monitor the company's ability to improve its financial performance and navigate regulatory challenges in the vaping industry. The absence of a dividend further emphasizes the speculative nature of this investment.
Based on FMP financials and quantitative analysis
ECGR Key Highlights
- Market Cap of $13.39M indicates a micro-cap company with limited resources and higher risk.
- P/E Ratio of -0.68 reflects current unprofitability, requiring investors to focus on future earnings potential.
- Profit Margin of -1562.3% signals significant operational challenges and potential financial instability.
- Gross Margin of 47.9% shows potential for profitability if operational costs are managed effectively.
- Beta of 2.76 indicates high volatility, suggesting the stock price is highly sensitive to market movements.
Who Are ECGR's Competitors?
ECGR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AVFCF ADVFN Plc | $0.27 | +0.00% | $12.50M | 45 |
| GTVI Joway Health Industries Group Inc. | $0.07 | +4.43% | $15.30M | 44 |
| KBPH Kyto Technology and Life Science, Inc. | $1.00 | -45.65% | $13.29M | 38 |
| LWLW Longwen Group Corp. | $0.10 | +0.00% | $8.09M | 56 |
| NSH NavSight Holdings, Inc. | $9.93 | +3.01% | 69 | |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.39M | 68 |
| LMAOU LMF Acquisition Opportunities, Inc. | $12.46 | +41.59% | 68 | |
| APXTW Apex Treasury Corporation | $0.37 | +5.11% | $1.96B | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ECGR's Key Strengths?
- Established brand in the vaping market.
- Proprietary eLiquid formulations.
- Distribution network in place.
- Focus on both tobacco and cannabis vaping.
What Are ECGR's Weaknesses?
- Limited financial resources.
- Negative profit margins.
- High beta indicating volatility.
- Dependence on a single industry.
What Could Drive ECGR Stock Higher?
- Potential regulatory changes in the vaping industry that could favor Bellatora's products.
- Expansion of distribution channels through strategic partnerships.
- Development and launch of new eLiquid flavors and vaporizer technologies.
What Are the Key Risks for ECGR?
- Financial-distress signal — its Altman Z-Score of -0.94 sits in the distress zone (elevated bankruptcy risk).
- Increasing regulatory restrictions on vaping products.
- Intense competition from larger, more established players.
- Negative profit margins and financial instability.
- Limited liquidity and price volatility due to OTC listing.
What Are the Growth Opportunities for ECGR?
- Expansion into Medicinal Cannabis Vaping: The increasing legalization of medicinal cannabis presents a significant growth opportunity for Bellatora. By developing and marketing vaporizers and eLiquids specifically designed for medicinal cannabis, Bellatora can tap into a growing market segment. This expansion requires compliance with varying state regulations and strategic partnerships with cannabis dispensaries. The medicinal cannabis market is projected to reach $55 billion by 2026, offering substantial revenue potential.
- Product Innovation and Differentiation: To stand out in the competitive vaping market, Bellatora must focus on product innovation. This includes developing new vaporizer technologies, flavors, and eLiquid formulations that appeal to a broad range of consumers. Investing in research and development to create unique and high-quality products can attract customers and build brand loyalty. The market for innovative vaping products is estimated at $10 billion annually.
- Strategic Partnerships and Distribution Channels: Establishing strategic partnerships with retailers, distributors, and online platforms can significantly expand Bellatora's reach and market penetration. Collaborating with established players in the vaping industry can provide access to new markets and customer segments. Exploring partnerships with convenience stores, vape shops, and online retailers can drive sales growth. The potential revenue from strategic partnerships is estimated at $5 million annually.
- Targeted Marketing and Branding: Effective marketing and branding are crucial for building brand awareness and attracting customers. Bellatora should focus on targeted marketing campaigns that highlight the unique features and benefits of its products. Utilizing social media, online advertising, and influencer marketing can reach a broad audience and drive sales. A strong brand identity can differentiate Bellatora from its competitors and build customer loyalty. The investment in targeted marketing is projected to yield a 20% increase in sales.
- Regulatory Compliance and Advocacy: Navigating the complex regulatory landscape of the vaping industry is essential for long-term success. Bellatora must ensure compliance with all applicable federal, state, and local regulations. Actively participating in industry advocacy efforts can help shape regulations that support the growth of the vaping market. Staying informed about regulatory changes and adapting business practices accordingly is crucial for maintaining a competitive advantage. The cost of regulatory compliance is estimated at $1 million annually.
What Opportunities Does ECGR Have?
- Expansion into new geographic markets.
- Development of innovative vaping products.
- Strategic partnerships with retailers and distributors.
- Capitalizing on the growing medicinal cannabis market.
What Threats Does ECGR Face?
- Increasing regulatory scrutiny of the vaping industry.
- Intense competition from larger players.
- Potential for product liability lawsuits.
- Changes in consumer preferences.
What Are ECGR's Competitive Advantages?
- Proprietary eLiquid formulations.
- Established distribution network within the vaping industry.
- Brand recognition among target customer segments.
What Does ECGR Do?
Bellatora Inc., originally founded as Oncology Med, underwent a transformation in September 2016, rebranding itself to focus on the electronic vaporizer market. The company manufactures, markets, and distributes electronic vaporizers, eLiquids, and ecigars designed for both tobacco and medicinal cannabis consumption. Headquartered in Anaheim, California, Bellatora aims to capitalize on the growing demand for alternative smoking products. The company's product line caters to a diverse customer base seeking alternatives to traditional smoking methods. Bellatora's strategic focus involves product development and marketing to expand its market share within the competitive vaping industry. However, as a smaller player, Bellatora faces significant challenges in competing with larger, more established companies that possess greater resources and brand recognition. The company's success hinges on its ability to innovate, differentiate its products, and effectively reach its target market while navigating the regulatory complexities of the vaping industry.
What Products and Services Does ECGR Offer?
- Manufactures electronic vaporizers for tobacco and cannabis.
- Markets electronic vaporizers for tobacco and cannabis.
- Distributes electronic vaporizers for tobacco and cannabis.
- Produces eLiquids for use in vaporizers.
- Creates ecigars as an alternative to traditional cigars.
- Targets tobacco users seeking alternatives to traditional smoking.
- Caters to medicinal cannabis users with specialized products.
How Does ECGR Make Money?
- Manufacturing and selling electronic vaporizers, eLiquids, and ecigars.
- Generating revenue through direct sales to consumers.
- Distributing products through retail channels and online platforms.
What Industry Does ECGR Operate In?
Bellatora Inc. operates within the evolving electronic vaporizer and eLiquid market, a segment experiencing both growth and increasing regulatory scrutiny. The industry is characterized by intense competition, with numerous players vying for market share. Companies like AVFCF, EXNN, GTVI, KBPH, and LWLW represent the competitive landscape. Market trends include a shift towards nicotine-free alternatives and increasing demand for medicinal cannabis vaping products. Bellatora's success depends on its ability to differentiate itself and navigate the regulatory environment effectively.
Who Are ECGR's Key Customers?
- Tobacco users seeking alternatives to traditional smoking.
- Medicinal cannabis users looking for vaporization options.
- Retailers and distributors of vaping products.
F-Score 4/9Financial Health
Bellatora Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.94 places it in the distress zone, a signal of elevated financial risk.
ROE 243%Key Financial Metrics
Return on equity for Bellatora Inc. stands at 243.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -27.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -35.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.28 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -111.9%, the inverse of the P/E and a quick read on earnings relative to price.
Bellatora Inc. (ECGR) Valuation Context
Valued at $13.39M, ECGR is classified as a micro-cap stock. Relative to its peer group, ECGR's quantitative score of 49/100 is roughly in line with the peer average of 50/100.
ECGR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates strong confidence from executives about the company's future prospects.
- Community sentiment has shifted positively, with increased discussions highlighting innovative product developments.
- Market perception is improving as Bellatora Inc. expands its market reach and enhances its brand recognition.
- Recent partnerships suggest strategic growth opportunities, fostering optimism among investors.
Bear Case
- Concerns about operational challenges have surfaced, causing some investors to question the company's execution capabilities.
- Negative sentiment from a segment of the community points to skepticism regarding the sustainability of recent growth.
- Increased competition in the sector may pressure profit margins, leading to cautious outlooks from analysts.
- Regulatory uncertainties surrounding new products could pose risks, contributing to a more bearish view among some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ECGR Latest News
No recent news available for ECGR.
ECGR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ECGR.
Price Targets
Wall Street price target analysis for ECGR.
ECGR MoonshotScore
What does this score mean?
The MoonshotScore rates ECGR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Edward Honour
CEO
Edward Honour serves as the Chief Executive Officer of Bellatora Inc. His background includes experience in the consumer goods and retail sectors. Prior to joining Bellatora, Honour held various leadership positions in marketing and sales, focusing on brand development and market expansion. His expertise lies in strategic planning, product innovation, and customer relationship management. He brings a customer-centric approach to Bellatora, aiming to enhance the company's market presence and drive revenue growth.
Track Record: Since assuming the role of CEO, Edward Honour has focused on streamlining operations and expanding Bellatora's product line. Key initiatives include the introduction of new eLiquid flavors and the development of strategic partnerships with distributors. Under his leadership, the company has navigated regulatory challenges and adapted to changing consumer preferences in the vaping market. His focus remains on improving financial performance and building long-term shareholder value.
ECGR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bellatora Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often face greater scrutiny and may have limited trading activity. Investing in OTC Other stocks carries higher risks due to the potential for less transparency and liquidity compared to stocks listed on major exchanges like the NYSE or NASDAQ. The information available to investors may be limited, requiring thorough due diligence.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Transparency: OTC stocks often have less stringent reporting requirements, making it difficult to assess their financial health.
- Low Liquidity: Trading volumes can be thin, leading to wider bid-ask spreads and potential difficulty in buying or selling shares.
- Regulatory Scrutiny: OTC-listed companies are subject to less regulatory oversight, increasing the risk of fraud or mismanagement.
- Price Volatility: The lack of liquidity and transparency can lead to significant price swings.
- Delisting Risk: Failure to meet minimum listing requirements could result in delisting from the OTC market.
- Verify the company's registration and legal standing.
- Obtain and review audited financial statements.
- Assess the company's management team and their track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's business model and revenue streams.
- Determine the company's disclosure status and reporting frequency.
- Monitor trading volume and price volatility.
- Independent Audits: Look for audited financial statements from reputable accounting firms.
- Management Team: Assess the experience and qualifications of the management team.
- Clear Business Model: Understand how the company generates revenue and creates value.
- Active Communication: Check for regular updates and communication with shareholders.
- Third-Party Validation: Seek out independent research reports or analyst coverage.
Bellatora Inc. Financial Services Stock: Key Questions Answered
What does Bellatora Inc. do?
Bellatora Inc. manufactures, markets, and distributes electronic vaporizers, eLiquids, and ecigars, primarily targeting tobacco and medicinal cannabis users. The company operates in the competitive vaping industry, focusing on product innovation and strategic partnerships to expand its market reach. Bellatora's business model centers around creating and selling alternative smoking products through various retail channels and online platforms. The company aims to differentiate itself through unique product offerings and targeted marketing efforts, while navigating the evolving regulatory landscape of the vaping industry.
What do analysts say about ECGR stock?
As of 2026-03-17, there is no readily available analyst coverage specifically for Bellatora Inc. (ECGR) due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and due diligence before considering an investment in ECGR. Key valuation metrics, such as P/E ratio and profit margin, indicate current unprofitability, requiring a focus on future earnings potential and operational improvements. The high beta suggests significant volatility, making it a speculative investment.
What are the main risks for ECGR?
Investing in Bellatora Inc. (ECGR) carries several risks, including increasing regulatory restrictions on vaping products, intense competition from larger players, negative profit margins, and financial instability. As an OTC-listed company, ECGR faces limited liquidity and price volatility. The lack of transparency and potential for regulatory scrutiny further amplify the risks. Investors should carefully assess these factors and conduct thorough due diligence before considering an investment in ECGR.
What are the key factors to evaluate for ECGR?
Bellatora Inc. (ECGR) holds an AI score of 49/100 (low). Not financial advice.
How frequently does ECGR data refresh on this page?
ECGR prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ECGR's recent stock price performance?
Bellatora Inc. (ECGR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand in the vaping market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ECGR overvalued or undervalued right now?
Valuing Bellatora Inc. (ECGR) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ECGR?
Before investing in Bellatora Inc. (ECGR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- Financial data based on available filings and may not be comprehensive.